Labcorp扩充检测项目,加速多种常见癌症复发监测。
Labcorp adds to its suite of tests to speed up detection of the recurrence of a range of common cancers
生物技术与制药领域的最新动态
Labcorp adds to its suite of tests to speed up detection of the recurrence of a range of common cancers
Pretzel emerges as winner from rise and fall of Rome Therapeutics
NIH loses yet another leader as heart, lung and blood director exits
Lyra ditches sole rhinosinusitis asset, lays off all employees
JPM26: Takeda’s R&D head talks slow Monday, the biggest threat to US innovation and a phoenix rebirth
Thermo Fisher Scientific teams up with Nvidia, TetraScience for next-gen AI workflow projects
JPM26: Bristol Myers CEO to 'cast a broad net' as business development remains a top priority
AbbVie pens $5.6B pact with RemeGen to join PD-1xVEGF bispecific battle
JPM26, Day 1: Stock market titans Lilly, Nvidia expand team-up with AI co-innovation lab
Boston Scientific snaps up Valencia Technologies to bolster urology offerings
Haemonetics to shell out up to €185M to acquire device maker Vivasure
Lilly, Nvidia tag on partnership with new AI co-innovation lab, $1B investment
Bayer boosts imaging portfolio with Attralus deal for 2 diagnostic tracers
Eikon next in line for IPO, with funds set to bankroll clutch of clinical cancer drugs
'An undoing of the scientific method': Flagship CEO warns of government threats to US biotech industry
China’s biotech moment goes global, Zai Lab exec says
Ohio Bets on Workforce Training to Capture Boom in Biomanufacturing, Digital Health
Quest Diagnostics highlights role of in vitro diagnostics in precision medicine
AirNexis takes flight with $200M, links up with China pharma for COPD asset in $955M biobucks deal
Orca rides $250M funding wave toward cancer cell therapy launch